GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Omnicare Inc (FRA:OMN) » Definitions » Total Stockholders Equity

Omnicare (FRA:OMN) Total Stockholders Equity : €2,273 Mil (As of Jun. 2015)


View and export this data going back to . Start your Free Trial

What is Omnicare Total Stockholders Equity?

Omnicare's Total Stockholders Equity for the quarter that ended in Jun. 2015 was €2,273 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Omnicare's Book Value per Share for the quarter that ended in Jun. 2015 was €23.46. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Omnicare's Debt-to-Equity for the quarter that ended in Jun. 2015 was 0.82.


Omnicare Total Stockholders Equity Historical Data

The historical data trend for Omnicare's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnicare Total Stockholders Equity Chart

Omnicare Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,884.85 2,884.53 2,671.35 2,000.79 2,099.45

Omnicare Quarterly Data
Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,913.62 2,060.13 2,099.45 2,333.30 2,272.61

Omnicare  (FRA:OMN) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Omnicare's Book Value per Share for the quarter that ended in Jun. 2015 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Omnicare's Debt-to-Equity for the quarter that ended in Jun. 2015 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omnicare Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Omnicare's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnicare (FRA:OMN) Business Description

Traded in Other Exchanges
N/A
Address
Omnicare Inc was formed in 1981 in Delaware. It is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group and Specialty Care Group. Through Long-Term Care Group, the Company provides pharmaceuticals and related pharmacy services to long-term care facilities as well as chronic care facilities and other settings. Through Specialty Care Group, the Company provides specialty pharmacy and commercialization services for the biopharmaceutical industry. The Company's businesses engage in an ongoing program for the development and marketing of new services. The Company serves long-term care institutions and other chronic care settings in approximately 47 states in the U.S. and the District of Columbia. The Company's largest competitor nationally is PharMerica Corporation. It also competes with numerous local and regional institutional pharmacies, pharmacies owned by long-term care facilities and local retail pharmacies. The Company is subject to extensive federal, state and local regulation.